INNOVEX INTERNATIONAL INC (INVX) Fundamental Analysis & Valuation

NYSE:INVX • US4576511079

Current stock price

24.01 USD
-0.3 (-1.23%)
At close:
23.62 USD
-0.39 (-1.62%)
After Hours:

This INVX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. INVX Profitability Analysis

1.1 Basic Checks

  • INVX had positive earnings in the past year.
  • INVX had a positive operating cash flow in the past year.
  • In multiple years INVX reported negative net income over the last 5 years.
  • INVX had a positive operating cash flow in 4 of the past 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of INVX (6.57%) is better than 83.33% of its industry peers.
  • INVX's Return On Equity of 7.88% is fine compared to the rest of the industry. INVX outperforms 73.33% of its industry peers.
  • INVX has a better Return On Invested Capital (8.28%) than 71.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for INVX is significantly below the industry average of 13.36%.
  • The last Return On Invested Capital (8.28%) for INVX is above the 3 year average (5.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.57%
ROE 7.88%
ROIC 8.28%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • INVX has a Profit Margin of 8.51%. This is in the better half of the industry: INVX outperforms 76.67% of its industry peers.
  • INVX has a better Operating Margin (11.63%) than 63.33% of its industry peers.
  • INVX has a better Gross Margin (31.00%) than 70.00% of its industry peers.
  • In the last couple of years the Gross Margin of INVX has grown nicely.
Industry RankSector Rank
OM 11.63%
PM (TTM) 8.51%
GM 31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. INVX Health Analysis

2.1 Basic Checks

  • INVX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for INVX remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, INVX has more shares outstanding
  • The debt/assets ratio for INVX has been reduced compared to a year ago.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • INVX has an Altman-Z score of 6.72. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of INVX (6.72) is better than 98.33% of its industry peers.
  • The Debt to FCF ratio of INVX is 0.16, which is an excellent value as it means it would take INVX, only 0.16 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of INVX (0.16) is better than 93.33% of its industry peers.
  • INVX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • INVX has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. INVX outperforms 88.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Altman-Z 6.72
ROIC/WACC0.94
WACC8.78%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • INVX has a Current Ratio of 4.91. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.91, INVX belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
  • INVX has a Quick Ratio of 3.24. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of INVX (3.24) is better than 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.91
Quick Ratio 3.24
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. INVX Growth Analysis

3.1 Past

  • INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 382.35%, which is quite impressive.
  • INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 74.11% yearly.
  • Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 26.86%.
  • The Revenue has been growing by 21.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)382.35%
EPS 3YN/A
EPS 5Y74.11%
EPS Q2Q%2.86%
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.83% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, INVX will show a small growth in Revenue. The Revenue will grow by 4.22% on average per year.
EPS Next Y57.04%
EPS Next 2Y37.29%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue Next Year3.75%
Revenue Next 2Y4.02%
Revenue Next 3Y4.22%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. INVX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.01, INVX can be considered very expensive at the moment.
  • INVX's Price/Earnings ratio is a bit cheaper when compared to the industry. INVX is cheaper than 68.33% of the companies in the same industry.
  • INVX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 15.93 indicates a correct valuation of INVX.
  • INVX's Price/Forward Earnings ratio is rather cheap when compared to the industry. INVX is cheaper than 81.67% of the companies in the same industry.
  • INVX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.01
Fwd PE 15.93
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVX is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, INVX is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.66
EV/EBITDA 8.61
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of INVX may justify a higher PE ratio.
  • INVX's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)0.34
EPS Next 2Y37.29%
EPS Next 3Y26.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INVX Dividend Analysis

5.1 Amount

  • No dividends for INVX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVX Fundamentals: All Metrics, Ratios and Statistics

INNOVEX INTERNATIONAL INC

NYSE:INVX (3/20/2026, 7:03:22 PM)

After market: 23.62 -0.39 (-1.62%)

24.01

-0.3 (-1.23%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-23
Earnings (Next)N/A
Inst Owners47.97%
Inst Owner Change3.68%
Ins Owners1.52%
Ins Owner Change0.58%
Market Cap1.66B
Revenue(TTM)978.25M
Net Income(TTM)83.30M
Analysts80
Price Target25.5 (6.21%)
Short Float %N/A
Short Ratio5.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.3%
Min EPS beat(2)-62.53%
Max EPS beat(2)7.93%
EPS beat(4)1
Avg EPS beat(4)-25.34%
Min EPS beat(4)-62.53%
Max EPS beat(4)7.93%
EPS beat(8)2
Avg EPS beat(8)-131.99%
EPS beat(12)2
Avg EPS beat(12)-130.16%
EPS beat(16)4
Avg EPS beat(16)-71.22%
Revenue beat(2)2
Avg Revenue beat(2)16.02%
Min Revenue beat(2)8.43%
Max Revenue beat(2)23.61%
Revenue beat(4)3
Avg Revenue beat(4)8.69%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)23.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.29%
EPS NQ rev (1m)-23.9%
EPS NQ rev (3m)-23.9%
EPS NY rev (1m)-7.57%
EPS NY rev (3m)-7.57%
Revenue NQ rev (1m)2.22%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE 25.01
Fwd PE 15.93
P/S 1.7
P/FCF 10.66
P/OCF 8.7
P/B 1.57
P/tB 1.97
EV/EBITDA 8.61
EPS(TTM)0.96
EY4%
EPS(NY)1.51
Fwd EY6.28%
FCF(TTM)2.25
FCFY9.38%
OCF(TTM)2.76
OCFY11.5%
SpS14.15
BVpS15.3
TBVpS12.17
PEG (NY)0.44
PEG (5Y)0.34
Graham Number18.18
Profitability
Industry RankSector Rank
ROA 6.57%
ROE 7.88%
ROCE 10.15%
ROIC 8.28%
ROICexc 10.12%
ROICexgc 13.23%
OM 11.63%
PM (TTM) 8.51%
GM 31%
FCFM 15.92%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)5.92%
ROICexc(5y)N/A
ROICexgc(3y)7.49%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Debt/EBITDA 0.11
Cap/Depr 57.84%
Cap/Sales 3.59%
Interest Coverage 111.19
Cash Conversion 109.41%
Profit Quality 187.02%
Current Ratio 4.91
Quick Ratio 3.24
Altman-Z 6.72
F-Score7
WACC8.78%
ROIC/WACC0.94
Cap/Depr(3y)69.66%
Cap/Depr(5y)61.2%
Cap/Sales(3y)4.45%
Cap/Sales(5y)4.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)382.35%
EPS 3YN/A
EPS 5Y74.11%
EPS Q2Q%2.86%
EPS Next Y57.04%
EPS Next 2Y37.29%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%
Revenue Next Year3.75%
Revenue Next 2Y4.02%
Revenue Next 3Y4.22%
Revenue Next 5YN/A
EBIT growth 1Y26.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.05%
EBIT Next 3Y28.79%
EBIT Next 5YN/A
FCF growth 1Y95.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.32%
OCF growth 3YN/A
OCF growth 5YN/A

INNOVEX INTERNATIONAL INC / INVX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Fairly Valued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 9 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.